Surgical Treatments of Tricuspid Valve Regurgitation After Cardiac Surgery

Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06554119

Enrollment

375

Registered

2024-08-15

Start date

1999-01-31

Completion date

2025-01-31

Last updated

2024-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tricuspid Valve Regurgitation; Complications, Longterm Outcome

Keywords

tricuspid valve regurgitation; technique advances; complications

Brief summary

This study aims to present our center's experience in managing postoperative tricuspid valve regurgitation over the past 25years and to analyze the outcomes of these surgical treatments.

Interventions

PROCEDUREHuanlei Huang

tricuspid valve replacement or plasty

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

16 Years to No maximum

Healthy volunteers

Inclusion criteria

patients who underwent surgical treatment from 1999 to 2023 for tricuspid valve disease following cardiac surgery

Exclusion criteria

age \<16，severe tricuspid regurgitation secondary to primary pulmonary hypertension, and those with substantial missing case data.

Design outcomes

Primary

Measure	Time frame	Description
death rate	1999-01 - 2025-01	perioperative and longterm
complications	1999-01 - 2025-01	perioperative and longterm complications

Secondary

Measure	Time frame	Description
redo of tricuspid valve	1999-01 - 2025-01	redo of tricuspid valve during the follow-up

Countries

China

Contacts

Primary ContactHuanlei Huang

hhuanlei@hotmail.com02083827812-10410

Backup ContactYingjie Ke

570706155@qq.com02083827812-10410

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026